About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Metabolic Changes as a Diagnostic Indicator for Cancer

NCT02362776·2 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Hasselt University

With

Ziekenhuis Oost-Limburg
Algemeen Ziekenhuis Vesalius
Ziekenhuis Maas en Kempen
Mariaziekenhuis Noord-Limburg

Age

Any age

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Diagnosis of breast or lung cancer (new lesion)

You may not be if

Not fasted for at least 6 hours
Plasma glucose concentration ≥ 200 mg/dl
Intake of medication at the day of investigation
History/treatment of cancer in the previous 5 years

The record

StatusCompleted

PhaseNo phase

Taking part426

StartedOct 2009

UpdatedFeb 13, 2015

Conditions

Breast Cancer Lung Cancer

Where2

Ziekenhuis Oost-Limburg
Genk, Limburg, Belgium
Hasselt University
Hasselt, Limburg, Belgium

Clareo Health | Metabolic Changes as a Diagnostic Indicator for Cancer